measure of drug safety, ration between dose producing toxicity and dose producing therapeutic effects
larger TI
greater margin of drug safety
low TI drug
monitor plasma conc levels (risk of adverse reaction)
drug potency
the amount of a drug required to produce a defined effect
more portent drug
less to produce effects
atenolol and metoprolol potency
atenolol more potent than metoprolol
drug effectiveness
how well achieves its purpose in a clinical sense, more effective has greater max level of effect
atenolol and metoprolol effectiveness
both achieve similar max level of anti-anginal effects (max effect same, but different dose)
differences in max effect of drug are more important than differences in potency
why are some drugs more effective than others
drugs act via different pathways, different capacity to produce desired effect and drugs have different capacity to modulate the activity of common target
morphine pathway action
activate u opioid receptor and increase descending pathway (suppress pain signal) and decrease ascending pathway (inhibit pain signal being relayed to brain), is a full agonist and effective
ibuprofen pathway
decrease production of prostaglandins to decrease pain sensitisation
drug selectivity
is the ability of drug to discriminate between targets, due to difference in affinity of drugs for targets, is not absolute is lost as drug conc increases
selective drug
high affinity for target, less adverse effects as lower affinity for other target
non selective drugs
similar affinity for multiple receptors, risk of adverse effects
structure activity relationship drugs
relationship between structural characteristics of a drug and its binding site and resultant effect
selectivity lost and antagonise the B2 receptor also which inhibits airways smooth muscle relaxation = risk for asthmatics
tramadol
a u opioid receptor antagonist and a serotonin-NA re-uptake inhibitor for pain relief
2 drugs used in combination for pre-exposure prophylaxis HIV prevention
TDF - 300 mg daily and TAF 25 mg daily
why give TAF and TDF together
TAF is converted in lymphocytes to tenofovir, toxicity is associated with TDF as covered to tenofovir in plasma = systemic exposure as is hydrophilic and hangs around can lead to renal toxicity
buprenorphine
a u opioid receptor partial agonist, relief withdrawal symptoms of opioid use disorder (given sublingually)
naloxone (and why given with buprenorphine)
a u opioid receptor antagonist, poorly absorbed sublingually but if i.v injected with antagonist the effects of buprenorphine, used to discourage misuse
drug tolerance
the diminished response to a drug following repeated or prolonged exposure
causes of drug tolerance
change in receptors, active extrusion of drug from cell, translocation of receptors, extrusion of mediators, increased metabolic degradation of drug, physiological adaptation
GABA
primary inhibitory nt in the CNS
example of ligand gated ion channel
GABAa receptor
GABAa activation
Cl- influx and hyperpolarisation, decreases neuronal excitability
example of enzyme linked receptor
insulin receptor
example of nuclear receptor
glucocorticoid receptor
what do synthetic glucocorticoids do
treat asthma, suppress pro inflammatory gene expression
insulin stimulated translocation of GLUT4
signal transduction creates sites for GSVs at cell membrane promotes translocation and exocytosis of GSVs = more GLUT4 at cell membrane for glucose uptake